Cargando…
An Imperfect Marker: SLE and TTP-Like MAHA Without Low ADAMTS13
Thrombotic thrombocytopenic purpura (TTP) is a potentially fatal condition that can be challenging for clinicians to identify in the setting of autoimmune diseases such as systemic lupus erythematosus (SLE). This difficulty is compounded when a patient presents with all of the clinical signs of a TT...
Autores principales: | Chiruvolu, Neha V., Scott, Jonathan, Yeh, Sam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267025/ https://www.ncbi.nlm.nih.gov/pubmed/34229453 http://dx.doi.org/10.1177/23247096211029746 |
Ejemplares similares
-
ADAMTS13, TTP and Beyond
por: Zheng, X Long
Publicado: (2012) -
P1612: CALPROTECTIN LEVELS ARE ELEVATED IN CONGENITAL TTP AND IMMUNE TTP AT ADAMTS13 RELAPSE
por: Subhan, Maryam, et al.
Publicado: (2023) -
Hydroxychloroquine, TTP, COVID-19, and SLE
por: Sookaromdee, Pathum, et al.
Publicado: (2021) -
P1598: UTILITY OF ‘OPEN/CLOSED’ ADAMTS13 IN MONITORING IMMUNE TTP
por: Prasannan, Nithya, et al.
Publicado: (2023) -
Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)